Olmesartan
Tocris Bioscience, part of Bio-Techne | Catalog # 4616
Potent AT1 antagonist
Discontinued Product
4616 has been discontinued.
View all Angiotensin AT1 Receptor Antagonists products.
Key Product Details
Description
Potent AT1 antagonist
Product Description
Olmesartan is a potent angiotensin II type I (AT1) receptor antagonist (IC50 = 6.7 nM at hAT1 receptors). Improves cognitive function in a mouse model of hypertension- and hyperlipidemia-associated cognitive decline; ameliorates arterial stiffness in a rat model of chronic renal failure.Product Specifications
Molecular Weight
446.50
Formula
C24H26N6O3
Storage
Store at +4°C
Purity
≥99% (HPLC)
Chemical Name
4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid
CAS Number
144689-24-7
PubChem ID
158781
InChI Key
VTRAEEWXHOVJFV-UHFFFAOYSA-N
SMILES
CCCC1=NC(C(C)(C)O)=C(C(O)=O)N1CC2=CC=C(C3=CC=CC=C3C4=NN=NN4)C=C2
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 8.93 | 20 |
Preparing Stock Solutions
for Olmesartan
The following data is based on the product molecular weight 446.50
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.2 mM | 11.20 mL | 55.99 mL | 111.98 mL |
| 1 mM | 2.24 mL | 11.20 mL | 22.40 mL |
| 2 mM | 1.12 mL | 5.60 mL | 11.20 mL |
| 10 mM | 0.22 mL | 1.12 mL | 2.24 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Chuang Effects of olmes. on arterial stiffness in rats with chronic renal failure. Cardiovasc.Diabetol. 2012 PMID: 22694778
- Ojima In vitro antagonistic properties of a new angiotensin type 1 receptor blocker, azilsartan, in receptor binding and function studies. J.Pharmacol.Exp.Ther. 2011 PMID: 21123673
- Mogi Inhibition of cognitive decline in mice fed a high-salt and cholesterol diet by the angiotensin receptor blocker, olmes. Neuropharmacology 2007 PMID: 18028965
Product Specific Notices for Olmesartan
For research use only
Loading...
Loading...